Biotechnology's infrastructure is crucial for innovation in health and agriculture but lacks adequate national security protection. The National Security Commission on Emerging Biotechnology urges classifying biotechnology alongside critical sectors like…
IO Biotech faces critical financial decisions as its cash reserves deplete, having $60 million at the start of December 2024 but burning $82 million annually. The company’s cash burn rate…
A surge in online search activity highlights growing investor interest in biotech companies. Biotie Therapies is at the forefront, focusing on transformative treatments for central nervous system disorders such as…
The global biotechnology race is intensifying, with the U.S. and China competing for dominance, impacting national security, economic balance, and technological progress. The National Security Commission on Emerging Biotechnology warns…
The U.S. is positioning itself as a leader in biotechnology through a strategic push championed by Senator Todd Young. Young's proposal suggests unifying various federal agencies to align under a…
Nourish Ingredients has introduced Tastilux®, a precision-fermented fat replicating real meat's savor without using animal products. Partnered with CABIO Biotech, they achieved large-scale production at reduced costs, underscoring commercial viability.…
Colossal Biosciences has achieved a groundbreaking scientific milestone by resurrecting the dire wolf, extinct for over 10,000 years. Named Romulus and Remus, these creatures symbolize the fusion of modern genetics…
Evaxion Biotech A/S is preparing transformative proposals for its Annual General Meeting on April 30, 2025, focusing on reshaping its identity and financial strength. The company specializes in AI-driven therapies…
Profound transformation is occurring in energy trading, encompassing oil, biofuels, carbon, ammonia, and hydrogen. Quantum Commodity Intelligence offers a platform for accessing insights into global markets, aiding informed decisions. Timely…
Otello Stampacchia, founder of Omega Funds, is noted for his candid critiques in the biotech investment world. Omega Funds, established in 2003, has invested in over 150 companies, contributing to…